Ruxience (rituximab-pvvr) Injection, 100 mg/10 mL Single-Dose Vial
Ruxience is a biosimilar to rituximab, supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 100 mg of rituximab-pvvr in 10 mL. It is indicated for the treatment of certain autoimmune conditions and malignancies, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Ruxience is a biosimilar to rituximab, supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 100 mg of rituximab-pvvr in 10 mL. It is indicated for the treatment of certain autoimmune conditions and malignancies, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
1 vendor
